As of 2025-04-22, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -14.29 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.10 USD, the upside of Cullinan Oncology Inc is -276.47%.
Based on its market price of 8.10 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 276.47%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.29 - -14.29 | -14.29 | -276.47% |
| P/E | (77.64) - (121.78) | (94.48) | -1266.4% |
| DDM - Stable | (13.21) - (31.96) | (22.59) | -378.9% |
| DDM - Multi | (9.90) - (19.89) | (13.35) | -264.8% |
| Market Cap (mil) | 473.93 |
| Beta | 1.02 |
| Outstanding shares (mil) | 58.51 |
| Enterprise Value (mil) | 390.93 |
| Market risk premium | 4.60% |
| Cost of Equity | 15.60% |
| Cost of Debt | 5.00% |
| WACC | 10.26% |